Literature DB >> 16241963

Rituximab-induced long-term remission in patients with refractory acquired hemophilia.

A Abdallah, D W Coghlan, E M Duncan, S D Chunilal, J V Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16241963     DOI： 10.1111/j.1538-7836.2005.01611.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.

Authors:  P Machado; J M Raya; T Martín; L Morabito; M L Brito; J M Rodríguez-Martín
Journal:  Int J Hematol       Date:  2008-04-15       Impact factor: 2.490

Review 2.  Rituximab for eradicating inhibitors in people with acquired haemophilia A.

Authors:  Tracey Remmington; Sherie Smith
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23

Review 3.  The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

Authors:  Giovanni D'arena; Elvira Grandone; Matteo N D Di Minno; Pellegrino Musto; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2015-09-03       Impact factor: 3.443
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.